… in promoting healthy prostate function and reducing urinary discomfort. Bottle … and supports normal prostate size, thereby enhancing urinary flow. Similarly, … (DHT), thereby reducing prostate enlargement and improving urinary flow. Additionally, Pygeum …

… had complete remission of proteinuria. Mean urine protein … and sustained reductions in proteinuria, according to researchers. … “In addition to reducing proteinuria, treatment with sparsentan also … and sustained reductions in urinary soluble CD163, a biomarker …

… DNA samples to calculate their prostate cancer risk, which is … high-risk through the standard prostate screening tool, 25 per … that tracks a protein called prostate-specific antigen (PSA). Elevated … either at higher risk of prostate cancer or are showing …

… predicts the risk of prostate cancer than current prostate-specific antigen (PSA … for genetic variants linked to prostate cancer and calculating a polygenic …

… the most aggressive form of prostate cancer, responsible for up to …

… behavior and can slow down prostate cancer progression. “Resistance to enzalutamide … enhances enzalutamide resistance in advanced prostate cancer,” said Yang. Finally, when … to overcome enzalutamide resistance in prostate cancer,” said Liu. More Kentucky …

… agents for metastatic castration-resistant prostate cancer, leveraging its high expression … and for treatment of metastatic prostate cancer using radiopharmaceuticals. We believe … agents for metastatic castration-resistant prostate cancer, leveraging its high …

… between muscle quality index and urinary incontinence among U.S. population … muscle quality index (MQI) and urinary incontinence (UI).   They performed a …

… and its phosphorylation (pNCC) in urinary extracellular vesicles (uEVs) and plasma … stages were classified using estimated glomerular filtration rate (eGFR). For … Cotransporter Abundance and Phosphorylation in Urinary Extracellular Vesicles From Patients …